Is dasatinib covered by medical insurance?

When leukemia cells have a genetic change called a Philadelphia chromosome (Philadelphia chromosome positive), doctors may give the patient treatment with dasatinib (Dasatinib). Doctors can test the patient's blood or bone marrow to look for the Philadelphia chromosome. Dasatinib is a drug called a tyrosine kinase inhibitor (TKI), which belongs to a group of targeted therapies called cancer growth inhibitors. Before a patient agrees to treatment, their doctor will discuss the treatment and its possible side effects.

Kinases are enzymes that promote cell growth and are proteins in the body that control cell growth and division. There are many types of kinases that control different stages of cell growth. The drug slows the growth of cancer cells by preventing a specific enzyme from working, blocking the signal that causes leukemia cells to die. Dasatinib is available as an oral tablet. Usually taken once a day with or without food. Take dasatinib at about the same time each day.

As far as dasatinib is concerned, the original drug is already on the market in China and has been included in the scope of medical insurance reimbursement in some areas. This means that patients who meet the medical insurance policy can enjoy a certain degree of cost reduction when purchasing dasatinib. This is undoubtedly good news for patients who require long-term treatment and can reduce their financial burden. Patients can consult the local medical insurance department or the hospital pharmacy for specific information about medical insurance reimbursement. It is understood that the normal price of dasatinib per box with specifications of 50mg*60 tablets and 20mg*60 tablets may be around RMB 10,000. Therefore, dasatinib is already within the scope of medical insurance reimbursement, and patients who meet the indications can use local medical insurance. The specific treatment policy is determined by the doctor.